168 related articles for article (PubMed ID: 37466663)
1. Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR.
Noteboom S; van Nederpelt DR; Bajrami A; Moraal B; Caan MWA; Barkhof F; Calabrese M; Vrenken H; Strijbis EMM; Steenwijk MD; Schoonheim MM
J Neurol; 2023 Nov; 270(11):5201-5210. PubMed ID: 37466663
[TBL] [Abstract][Full Text] [Related]
2. Reliability of brain atrophy measurements in multiple sclerosis using MRI: an assessment of six freely available software packages for cross-sectional analyses.
van Nederpelt DR; Amiri H; Brouwer I; Noteboom S; Mokkink LB; Barkhof F; Vrenken H; Kuijer JPA
Neuroradiology; 2023 Oct; 65(10):1459-1472. PubMed ID: 37526657
[TBL] [Abstract][Full Text] [Related]
3. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
[TBL] [Abstract][Full Text] [Related]
4. DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis.
Dwyer M; Lyman C; Ferrari H; Bergsland N; Fuchs TA; Jakimovski D; Schweser F; Weinstock-Guttmann B; Benedict RHB; Riolo J; Silva D; Zivadinov R
Neuroimage Clin; 2021; 30():102652. PubMed ID: 33872992
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
6. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Akaishi T; Takahashi T; Fujihara K; Misu T; Mugikura S; Abe M; Ishii T; Aoki M; Nakashima I
PLoS One; 2020; 15(4):e0231225. PubMed ID: 32243459
[TBL] [Abstract][Full Text] [Related]
7. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
[TBL] [Abstract][Full Text] [Related]
8. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
9. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
[TBL] [Abstract][Full Text] [Related]
11. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
13. The role of cerebellar damage in explaining disability and cognition in multiple sclerosis phenotypes: a multiparametric MRI study.
Bonacchi R; Meani A; Pagani E; Marchesi O; Filippi M; Rocca MA
J Neurol; 2022 Jul; 269(7):3841-3857. PubMed ID: 35230471
[TBL] [Abstract][Full Text] [Related]
14. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
15. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
[TBL] [Abstract][Full Text] [Related]
16. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
17. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
[TBL] [Abstract][Full Text] [Related]
18. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
19. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
Zivadinov R; Bergsland N; Korn JR; Dwyer MG; Khan N; Medin J; Price JC; Weinstock-Guttman B; Silva D;
AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]